Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
Want to see BRNS full AI Analyst Report?
Technical Sentiment
Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Barinthus Biotherapeutics’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Barinthus Biotherapeutics is a Sell.
Barinthus Biotherapeutics’s (BRNS) 20-Day exponential moving average is 0.58, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Buy.
Barinthus Biotherapeutics’s (BRNS) 50-Day exponential moving average is 0.62, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics (BRNS) Pivot Points
Classic
0.56
0.58
0.58
0.60
0.60
0.62
0.62
Fibonacci
0.58
0.58
0.59
0.60
0.60
0.61
0.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Barinthus Biotherapeutics (BRNS) Moving Averages
MA5
0.58Buy
0.59Buy
MA10
0.57Buy
0.58Buy
MA20
0.57Buy
0.58Buy
MA50
0.60Sell
0.62Sell
MA100
0.66Sell
0.70Sell
MA200
0.95Sell
0.86Sell
Barinthus Biotherapeutics’s (BRNS) 10-Day exponential moving average is 0.58, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Buy.
Barinthus Biotherapeutics’s (BRNS) 100-Day exponential moving average is 0.70, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 50-day simple moving average is 0.60, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 100-day simple moving average is 0.66, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 200-day simple moving average is 0.95, creating a Sell signal.
Barinthus Biotherapeutics (BRNS) Technical Indicators
RSI (14)
50.49
Neutral
STOCH (9,6)
50.00
Neutral
STOCHRSI (14)
57.98
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
20.16
Neutral
Williams %R
-42.02
Buy
CCI (14)
74.87
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
26.83
Sell
ROC
7.27
Buy
Barinthus Biotherapeutics’s (BRNS) Relative Strength Index (RSI) is 50.49, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Trend Strength Indicator (ADX) is 20.16, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Commodity Channel Index (CCI) is 74.87, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Price Rate of Change (ROC) is 7.27, creating a Buy signal.
FAQ
Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Hold.
What is BRNS’s RSI (14)?
BRNS’s RSI (14) is 50.49, which suggests BRNS is a Neutral.
What is BRNS’s MACD?
BRNS’s MACD is >-0.01, which suggests BRNS is a Sell.
What is BRNS’s 5-day moving average?
BRNS’s 5-day moving average is 0.58, which suggests BRNS is a Buy.
What is BRNS’s 20-day moving average?
BRNS 20-day moving average is 0.57, which suggests BRNS is a Buy.
What is BRNS’s 50-day moving average?
BRNS’s 50-day moving average is 0.60, which suggests BRNS is a Sell.
What is BRNS’s 200-day moving average?
BRNS’s 200-day moving average is 0.95, which suggests BRNS is a Sell.
What is BRNS’s Williams % R (14)?
BRNS’s Williams % R (14) is -42.02, which suggests BRNS is a Buy.
What is BRNS’s CCI (14)?
BRNS’s CCI (14) is 74.87, which suggests BRNS is a Neutral.